The broad practice at Pearl Cohen Zedek Latzer Baratz acts for a varied client base of tech transfer companies, healthcare start-ups, and major pharma corporations. All co-heading the practice, Yael Baratz leads on the corporate and licensing side of the practice, handling cross-border M&A and non-dilutive financing issues; Hili Rashkovan regularly assists clients with joint development agreements and clinical trials; and Baruch Avrahami is well-known for advising hospitals and healthcare companies. Dividing their time between Tel Aviv and New York, practice co-head Mark Cohen's primary areas of focus are pharma and medical device related patent prosecutions, and co-head Zeev Pearl is noted for his longstanding expertise in IP portfolio development and licensing disputes.
Key clients
- Bayit Balev
- Bayer AG
Work highlights
- Representing Bayer (including Bayer Intellectual Property Gmbh, Bayer's IP arm, and Bayer S.A.S), Sanofi, Pfizer, and Illumina in patent prosecution matters.
- Advising Orgenesis, a global service provider in the regenerative medicine industry, and its subsidiaries in Israel, Belgium and Korea, on M&A commercial, corporate and IP issues.